share_log

信達生物:自願公告 - 國家藥品監督管理局受理ROS1抑制劑泰萊替尼的新藥上市申請

INNOVENT BIO: VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTED THE NEW DRUG APPLICATION FOR TALETRECTINIB (ROS1 INHIBITOR)

香港交易所 ·  Nov 22, 2023 03:43
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more